Fact CheckerSign in

NCT05076747Completed

Exercise and Genotype in Sub-acute Stroke

Promoting Brain Plasticity During Sub-acute Stroke: the Interactive Role of Exercise and Genotype

Source: ClinicalTrials.gov · Last updated 11 Dec 2024

Brief summary (registry, in English)

This study will investigate the impact of cardiovascular exercise on brain plasticity among patients in sub-acute stages after stroke, and whether genotype modulates the response to this intervention. Participants in the experimental group will perform cardiovascular training for 8 weeks, three times/week in addition to standard therapy, while participants in the control group will perform standard therapy only. Assessments will be performed at baseline, four weeks, and 8 weeks after training.

Status (registry)
Completed
Study type
Interventional
Enrollment
70 (actual)
First submitted
21 Sept 2021
Start date
Jun 2021
Primary completion date
Nov 2023
Lead sponsor
McGill University
Diseases
Stroke
NCT number
NCT05076747

What you commit to

  • Study type: Interventional
  • Participants enrolled: 70
  • From Jun 2021 to the primary completion date, Nov 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Major psychiatric or previous neurological disease

Other illness

  • Hemorrhagic stroke
  • Cognitive impairment/dysphasia affecting informed consent

Other

  • Concurrently enrolled in another exercise program
  • Absolute contraindications to TMS or exercise

Who the study is looking for

  • Individuals 40-80 years old
  • Who had a first-ever ischemic (cortical or subcortical) stroke confirmed by MRI/CT
  • Who had stroke 2 to 6 weeks prior to participation
  • With recordable motor-evoked potentials (MEPs) elicited with transcranial magnetic stimulation (TMS) from the affected hemisphere
  • With no serious musculoskeletal or neurological conditions other than stroke
  • With sufficient cognitive/communicative capacity to safely perform the protocols.

Age in the registry: 40 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Jewish Rehabiliation Hospital
Coordinator of this site? Confirm its status
LavalCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.